Smith & Nephew has agreed to acquire Blue Belt Holdings, Inc. for $275 million, securing a leading position in the...
The FDA has approved Axumin (fluciclovine (18F)), a radioactive diagnostic agent for injection from Blue Earth Diagnostics Ltd. Axumin is...
Blue Belt Technologies has received 510(k) clearance from the FDA to market its NavioPFS orthopedic surgical system. The clearance is...